Cite
Use of programmed cell death protein 1 (PD-1) inhibitor therapy in HIV-infected patients with advanced cancer: a single-center study from China.
MLA
Wu, Luling, et al. “Use of Programmed Cell Death Protein 1 (PD-1) Inhibitor Therapy in HIV-Infected Patients with Advanced Cancer: A Single-Center Study from China.” Infectious Agents & Cancer, vol. 18, no. 1, May 2023, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13027-023-00512-z.
APA
Wu, L., Su, J., Yang, J., Gu, L., Zhang, R., Liu, L., Lu, H., & Chen, J. (2023). Use of programmed cell death protein 1 (PD-1) inhibitor therapy in HIV-infected patients with advanced cancer: a single-center study from China. Infectious Agents & Cancer, 18(1), 1–10. https://doi.org/10.1186/s13027-023-00512-z
Chicago
Wu, Luling, Jie Su, Junyang Yang, Ling Gu, Renfang Zhang, Li Liu, Hongzhou Lu, and Jun Chen. 2023. “Use of Programmed Cell Death Protein 1 (PD-1) Inhibitor Therapy in HIV-Infected Patients with Advanced Cancer: A Single-Center Study from China.” Infectious Agents & Cancer 18 (1): 1–10. doi:10.1186/s13027-023-00512-z.